Hereditary Hemorrhagic Telangiectasia, Clinical Presentations, and Management

Stroke. 2023 Dec;54(12):e512-e515. doi: 10.1161/STROKEAHA.123.043645. Epub 2023 Oct 23.

Authors

Luke Silveira¹, John Muse¹, Katrina Ducis¹

Affiliation

¹ Division of Neurosurgery, The University of Vermont Medical Center, Burlington.

PMID: 37869888
DOI: 10.1161/STROKEAHA.123.043645

No abstract available

Keywords: arteriovenous malformations; endoglin; epistaxis; neurosurgery; telangiectasia, hereditary hemorrhagic.

MeSH terms

Activin Receptors, Type II
Arteriovenous Malformations*
Endoglin
Humans
Telangiectasia, Hereditary Hemorrhagic* / diagnosis
Telangiectasia, Hereditary Hemorrhagic* / genetics
Telangiectasia, Hereditary Hemorrhagic* / therapy

Substances

Endoglin
Activin Receptors, Type II